723 related articles for article (PubMed ID: 30730411)
21. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
Giri VN; Hegarty SE; Hyatt C; O'Leary E; Garcia J; Knudsen KE; Kelly WK; Gomella LG
Prostate; 2019 Mar; 79(4):333-339. PubMed ID: 30450585
[TBL] [Abstract][Full Text] [Related]
22. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Pritchard CC; Mateo J; Walsh MF; De Sarkar N; Abida W; Beltran H; Garofalo A; Gulati R; Carreira S; Eeles R; Elemento O; Rubin MA; Robinson D; Lonigro R; Hussain M; Chinnaiyan A; Vinson J; Filipenko J; Garraway L; Taplin ME; AlDubayan S; Han GC; Beightol M; Morrissey C; Nghiem B; Cheng HH; Montgomery B; Walsh T; Casadei S; Berger M; Zhang L; Zehir A; Vijai J; Scher HI; Sawyers C; Schultz N; Kantoff PW; Solit D; Robson M; Van Allen EM; Offit K; de Bono J; Nelson PS
N Engl J Med; 2016 Aug; 375(5):443-53. PubMed ID: 27433846
[TBL] [Abstract][Full Text] [Related]
23. Molecular insights into the germline for prostate cancer initiation, progression, and aggressiveness.
Pritchard CC
Can J Urol; 2019 Oct; 26(5 Suppl 2):24-26. PubMed ID: 31629422
[TBL] [Abstract][Full Text] [Related]
24. Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.
Cheng HH; Sokolova AO; Gulati R; Bowen D; Knerr SA; Klemfuss N; Grivas P; Hsieh A; Lee JK; Schweizer MT; Yezefski T; Zhou A; Yu EY; Nelson PS; Montgomery B
JCO Precis Oncol; 2023 Jan; 7():e2200104. PubMed ID: 36623239
[TBL] [Abstract][Full Text] [Related]
25. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
Giri VN; Hartman R; Pritzlaff M; Horton C; Keith SW
JCO Precis Oncol; 2022 May; 6(1):e2200234. PubMed ID: 35666082
[TBL] [Abstract][Full Text] [Related]
26. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Paller CJ; Antonarakis ES; Beer TM; Borno HT; Carlo MI; George DJ; Graff JN; Gupta S; Heath EI; Higano CS; McKay RR; Morgans AK; Patnaik A; Petrylak DP; Rettig MB; Ryan CJ; Taplin ME; Whang YE; Vinson J; Cheng HH; Giri VN;
Clin Genitourin Cancer; 2019 Aug; 17(4):275-282.e1. PubMed ID: 31171481
[TBL] [Abstract][Full Text] [Related]
27. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Giri VN; Knudsen KE; Kelly WK; Cheng HH; Cooney KA; Cookson MS; Dahut W; Weissman S; Soule HR; Petrylak DP; Dicker AP; AlDubayan SH; Toland AE; Pritchard CC; Pettaway CA; Daly MB; Mohler JL; Parsons JK; Carroll PR; Pilarski R; Blanco A; Woodson A; Rahm A; Taplin ME; Polascik TJ; Helfand BT; Hyatt C; Morgans AK; Feng F; Mullane M; Powers J; Concepcion R; Lin DW; Wender R; Mark JR; Costello A; Burnett AL; Sartor O; Isaacs WB; Xu J; Weitzel J; Andriole GL; Beltran H; Briganti A; Byrne L; Calvaresi A; Chandrasekar T; Chen DYT; Den RB; Dobi A; Crawford ED; Eastham J; Eggener S; Freedman ML; Garnick M; Gomella PT; Handley N; Hurwitz MD; Izes J; Karnes RJ; Lallas C; Languino L; Loeb S; Lopez AM; Loughlin KR; Lu-Yao G; Malkowicz SB; Mann M; Mille P; Miner MM; Morgan T; Moreno J; Mucci L; Myers RE; Nielsen SM; O'Neil B; Pinover W; Pinto P; Poage W; Raj GV; Rebbeck TR; Ryan C; Sandler H; Schiewer M; Scott EMD; Szymaniak B; Tester W; Trabulsi EJ; Vapiwala N; Yu EY; Zeigler-Johnson C; Gomella LG
J Clin Oncol; 2020 Aug; 38(24):2798-2811. PubMed ID: 32516092
[TBL] [Abstract][Full Text] [Related]
28. Germline BRCA mutation in male carriers-ripe for precision oncology?
Leão RRN; Price AJ; James Hamilton R
Prostate Cancer Prostatic Dis; 2018 Apr; 21(1):48-56. PubMed ID: 29242595
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Nicolosi P; Ledet E; Yang S; Michalski S; Freschi B; O'Leary E; Esplin ED; Nussbaum RL; Sartor O
JAMA Oncol; 2019 Apr; 5(4):523-528. PubMed ID: 30730552
[TBL] [Abstract][Full Text] [Related]
30. Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.
Carter HB; Helfand B; Mamawala M; Wu Y; Landis P; Yu H; Wiley K; Na R; Shi Z; Petkewicz J; Shah S; Fantus RJ; Novakovic K; Brendler CB; Zheng SL; Isaacs WB; Xu J
Eur Urol; 2019 May; 75(5):743-749. PubMed ID: 30309687
[TBL] [Abstract][Full Text] [Related]
31. Observed evidence for guideline-recommended genes in predicting prostate cancer risk from a large population-based cohort.
Wei J; Yang W; Shi Z; Lu L; Wang Q; Resurreccion WK; Engelmann V; Zheng SL; Hulick PJ; Cooney KA; Isaacs WB; Helfand BT; Lu J; Xu J
Prostate; 2021 Sep; 81(13):1002-1008. PubMed ID: 34254341
[TBL] [Abstract][Full Text] [Related]
32. Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications.
Brandão A; Paulo P; Teixeira MR
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708810
[TBL] [Abstract][Full Text] [Related]
33. Genetically Informed Prostate Cancer Treatment for Metastatic Disease.
Siebert AL; Szymaniak BM; Numan Y; Morgans AK
Urol Clin North Am; 2021 Aug; 48(3):365-371. PubMed ID: 34210491
[TBL] [Abstract][Full Text] [Related]
34. Whole-exome Sequencing of Nigerian Prostate Tumors from the Prostate Cancer Transatlantic Consortium (CaPTC) Reveals DNA Repair Genes Associated with African Ancestry.
White JA; Kaninjing ET; Adeniji KA; Jibrin P; Obafunwa JO; Ogo CN; Mohammed F; Popoola A; Fatiregun OA; Oluwole OP; Karanam B; Elhussin I; Ambs S; Tang W; Davis M; Polak P; Campbell MJ; Brignole KR; Rotimi SO; Dean-Colomb W; Odedina FT; Martin DN; Yates C
Cancer Res Commun; 2022 Sep; 2(9):1005-1016. PubMed ID: 36922933
[TBL] [Abstract][Full Text] [Related]
35. Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
Sessine MS; Das S; Park B; Salami SS; Kaffenberger SD; Kasputis A; Solorzano M; Luke M; Vince RA; Kaye DR; Borza T; Stoffel EM; Cobain E; Merajver SD; Jacobs MF; Milliron KJ; Caba L; van Neste L; Mondul AM; Morgan TM
Urology; 2021 Oct; 156():96-103. PubMed ID: 34280438
[TBL] [Abstract][Full Text] [Related]
36. A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer.
Kerr L; Rewhorn MJ; Longmuir M; Fraser S; Walsh S; Andrew N; Leung HY
BMC Cancer; 2016 Jul; 16():529. PubMed ID: 27456091
[TBL] [Abstract][Full Text] [Related]
37. Germline Testing in Prostate Cancer: When and Who to Test.
Sokolova A; Cheng H
Oncology (Williston Park); 2021 Oct; 35(10):645-653. PubMed ID: 34669358
[TBL] [Abstract][Full Text] [Related]
38. Short-Term Outcomes of Active Surveillance for Low Risk Prostate Cancer among Men with Germline DNA Repair Gene Mutations.
Halstuch D; Ber Y; Kedar D; Golan S; Baniel J; Margel D
J Urol; 2020 Oct; 204(4):707-713. PubMed ID: 32191583
[TBL] [Abstract][Full Text] [Related]
39. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
Loeb S; Giri VN
Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
[TBL] [Abstract][Full Text] [Related]
40. Inherited DNA-repair gene mutations in African American men with prostate cancer.
Sartor O; Yang S; Ledet E; Moses M; Nicolosi P
Oncotarget; 2020 Jan; 11(4):440-442. PubMed ID: 32064047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
